List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Psychedelic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychedelic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psychedelic Drugs Overall Market Size
2.1 Global Psychedelic Drugs Market Size: 2021 VS 2028
2.2 Global Psychedelic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psychedelic Drugs Players in Global Market
3.2 Top Global Psychedelic Drugs Companies Ranked by Revenue
3.3 Global Psychedelic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psychedelic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Psychedelic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psychedelic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Psychedelic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Psychedelic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Psychedelic Drugs Market Size Markets, 2021 & 2028
4.1.2 Psilocybin
4.1.3 LSD
4.1.4 MDMA
4.1.5 DMT
4.1.6 Ketamine
4.1.7 Others
4.2 By Type - Global Psychedelic Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychedelic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Psychedelic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Psychedelic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psychedelic Drugs Market Size, 2021 & 2028
5.1.2 Depressive Disorders
5.1.3 Post-Traumatic Stress Disorders
5.1.4 Substance Abuse Disorders
5.1.5 Obsessive Compulsive Disorders
5.1.6 Others
5.2 By Application - Global Psychedelic Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychedelic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Psychedelic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Psychedelic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Psychedelic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Psychedelic Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychedelic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Psychedelic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Psychedelic Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Psychedelic Drugs Revenue, 2017-2028
6.3.2 US Psychedelic Drugs Market Size, 2017-2028
6.3.3 Canada Psychedelic Drugs Market Size, 2017-2028
6.3.4 Mexico Psychedelic Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Psychedelic Drugs Revenue, 2017-2028
6.4.2 Germany Psychedelic Drugs Market Size, 2017-2028
6.4.3 France Psychedelic Drugs Market Size, 2017-2028
6.4.4 U.K. Psychedelic Drugs Market Size, 2017-2028
6.4.5 Italy Psychedelic Drugs Market Size, 2017-2028
6.4.6 Russia Psychedelic Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Psychedelic Drugs Market Size, 2017-2028
6.4.8 Benelux Psychedelic Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Psychedelic Drugs Revenue, 2017-2028
6.5.2 China Psychedelic Drugs Market Size, 2017-2028
6.5.3 Japan Psychedelic Drugs Market Size, 2017-2028
6.5.4 South Korea Psychedelic Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Psychedelic Drugs Market Size, 2017-2028
6.5.6 India Psychedelic Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Psychedelic Drugs Revenue, 2017-2028
6.6.2 Brazil Psychedelic Drugs Market Size, 2017-2028
6.6.3 Argentina Psychedelic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psychedelic Drugs Revenue, 2017-2028
6.7.2 Turkey Psychedelic Drugs Market Size, 2017-2028
6.7.3 Israel Psychedelic Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Psychedelic Drugs Market Size, 2017-2028
6.7.5 UAE Psychedelic Drugs Market Size, 2017-2028
7 Players Profiles
7.1 COMPASS Pathways PLC
7.1.1 COMPASS Pathways PLC Corporate Summary
7.1.2 COMPASS Pathways PLC Business Overview
7.1.3 COMPASS Pathways PLC Psychedelic Drugs Major Product Offerings
7.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue in Global Market (2017-2022)
7.1.5 COMPASS Pathways PLC Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Psychedelic Drugs Major Product Offerings
7.2.4 Pfizer Psychedelic Drugs Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Psychedelic Drugs Major Product Offerings
7.3.4 Eli Lilly Psychedelic Drugs Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Psychedelic Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Psychedelic Drugs Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Cybin Inc
7.5.1 Cybin Inc Corporate Summary
7.5.2 Cybin Inc Business Overview
7.5.3 Cybin Inc Psychedelic Drugs Major Product Offerings
7.5.4 Cybin Inc Psychedelic Drugs Revenue in Global Market (2017-2022)
7.5.5 Cybin Inc Key News
7.6 Field Trip Health
7.6.1 Field Trip Health Corporate Summary
7.6.2 Field Trip Health Business Overview
7.6.3 Field Trip Health Psychedelic Drugs Major Product Offerings
7.6.4 Field Trip Health Psychedelic Drugs Revenue in Global Market (2017-2022)
7.6.5 Field Trip Health Key News
7.7 ATAI Life Sciences
7.7.1 ATAI Life Sciences Corporate Summary
7.7.2 ATAI Life Sciences Business Overview
7.7.3 ATAI Life Sciences Psychedelic Drugs Major Product Offerings
7.7.4 ATAI Life Sciences Psychedelic Drugs Revenue in Global Market (2017-2022)
7.7.5 ATAI Life Sciences Key News
7.8 NUMINUS WELLNESS
7.8.1 NUMINUS WELLNESS Corporate Summary
7.8.2 NUMINUS WELLNESS Business Overview
7.8.3 NUMINUS WELLNESS Psychedelic Drugs Major Product Offerings
7.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue in Global Market (2017-2022)
7.8.5 NUMINUS WELLNESS Key News
7.9 MindMed
7.9.1 MindMed Corporate Summary
7.9.2 MindMed Business Overview
7.9.3 MindMed Psychedelic Drugs Major Product Offerings
7.9.4 MindMed Psychedelic Drugs Revenue in Global Market (2017-2022)
7.9.5 MindMed Key News
7.10 HAVN Life Sciences
7.10.1 HAVN Life Sciences Corporate Summary
7.10.2 HAVN Life Sciences Business Overview
7.10.3 HAVN Life Sciences Psychedelic Drugs Major Product Offerings
7.10.4 HAVN Life Sciences Psychedelic Drugs Revenue in Global Market (2017-2022)
7.10.5 HAVN Life Sciences Key News
7.11 Seelos Therapeutics
7.11.1 Seelos Therapeutics Corporate Summary
7.11.2 Seelos Therapeutics Business Overview
7.11.3 Seelos Therapeutics Psychedelic Drugs Major Product Offerings
7.11.4 Seelos Therapeutics Psychedelic Drugs Revenue in Global Market (2017-2022)
7.11.5 Seelos Therapeutics Key News
7.12 Jannsen
7.12.1 Jannsen Corporate Summary
7.12.2 Jannsen Business Overview
7.12.3 Jannsen Psychedelic Drugs Major Product Offerings
7.12.4 Jannsen Psychedelic Drugs Revenue in Global Market (2017-2022)
7.12.5 Jannsen Key News
7.13 Acadia Pharmaceuticals
7.13.1 Acadia Pharmaceuticals Corporate Summary
7.13.2 Acadia Pharmaceuticals Business Overview
7.13.3 Acadia Pharmaceuticals Psychedelic Drugs Major Product Offerings
7.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue in Global Market (2017-2022)
7.13.5 Acadia Pharmaceuticals Key News
7.14 Intellipharmaceutics
7.14.1 Intellipharmaceutics Corporate Summary
7.14.2 Intellipharmaceutics Business Overview
7.14.3 Intellipharmaceutics Psychedelic Drugs Major Product Offerings
7.14.4 Intellipharmaceutics Psychedelic Drugs Revenue in Global Market (2017-2022)
7.14.5 Intellipharmaceutics Key News
7.15 Revive Therapeutics
7.15.1 Revive Therapeutics Corporate Summary
7.15.2 Revive Therapeutics Business Overview
7.15.3 Revive Therapeutics Psychedelic Drugs Major Product Offerings
7.15.4 Revive Therapeutics Psychedelic Drugs Revenue in Global Market (2017-2022)
7.15.5 Revive Therapeutics Key News
7.16 Mydecine Innovations Group
7.16.1 Mydecine Innovations Group Corporate Summary
7.16.2 Mydecine Innovations Group Business Overview
7.16.3 Mydecine Innovations Group Psychedelic Drugs Major Product Offerings
7.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue in Global Market (2017-2022)
7.16.5 Mydecine Innovations Group Key News
7.17 Red Light Holland
7.17.1 Red Light Holland Corporate Summary
7.17.2 Red Light Holland Business Overview
7.17.3 Red Light Holland Psychedelic Drugs Major Product Offerings
7.17.4 Red Light Holland Psychedelic Drugs Revenue in Global Market (2017-2022)
7.17.5 Red Light Holland Key News
7.18 Braxia Scientific
7.18.1 Braxia Scientific Corporate Summary
7.18.2 Braxia Scientific Business Overview
7.18.3 Braxia Scientific Psychedelic Drugs Major Product Offerings
7.18.4 Braxia Scientific Psychedelic Drugs Revenue in Global Market (2017-2022)
7.18.5 Braxia Scientific Key News
7.19 Mind Cure Health
7.19.1 Mind Cure Health Corporate Summary
7.19.2 Mind Cure Health Business Overview
7.19.3 Mind Cure Health Psychedelic Drugs Major Product Offerings
7.19.4 Mind Cure Health Psychedelic Drugs Revenue in Global Market (2017-2022)
7.19.5 Mind Cure Health Key News
7.20 Entheon Biomedical
7.20.1 Entheon Biomedical Corporate Summary
7.20.2 Entheon Biomedical Business Overview
7.20.3 Entheon Biomedical Psychedelic Drugs Major Product Offerings
7.20.4 Entheon Biomedical Psychedelic Drugs Revenue in Global Market (2017-2022)
7.20.5 Entheon Biomedical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
